05 February 2018 | News
This acquisition provides Eurofins an entry platform into the clinical testing market in Belgium and a license to operate and sell its specialties in this market.
Image credit- gtb.com
Eurofins Scientific has recently announced the acquisition of Labo Van Poucke (LVP), a leading laboratory performing human medical testing covering all branches of clinical biology.
LVP is licensed by the Belgian Scientific Institute of Public Health (WIV-ISP) for clinical pathology testing. The company is also licensed by the Belgian Federal Agency for Nuclear Control (FANC) for isotopic tests.
LVP has been accredited by the Belgian Accreditation Body (BELAC) since 1997, and operates in compliance with the ISO 15189 standard for medical laboratories. LVP employs 34 staff and generated revenues close to EUR 5 million in 2017.
This acquisition provides Eurofins an entry platform into the clinical testing market in Belgium and a license to operate and sell its specialties in this market.
LVP offers testing for hematology, serology, chemistry, immunology, microbiology and molecular biology.
LVP’s broad range of testing services, combined with LifeCodexx’s and Genoma’s clinical genetics capabilities acquired in 2017, significantly strengthens Eurofins’ growing footprint in the specialty clinical diagnostics testing market in Europe.